Analyzing the relationships between travel mode indicators and the number of passenger transport fatalities at the city level

Traffic Injury Prevention
Zohreh Asadi-ShekariAmran Hamzah

Abstract

A number of efforts have been conducted on travel behavior and transport fatalities at the neighborhood or street level, and they have identified different factors such as roadway characteristics, personal indicators, and design indicators related to transport safety. However, only a limited number of studies have considered the relationship between travel behavior indicators and the number of transport fatalities at the city level. Therefore, this study explores this relationship and how to fill the mentioned gap in current knowledge. A generalized linear model (GLM) estimates the relationships between different travel mode indicators (e.g., length of motorway per inhabitants, number of motorcycles per inhabitant, percentage of daily trips on foot and by bicycle, percentage of daily trips by public transport) and the number of passenger transport fatalities. Because this city-level model is developed using data sets from different cities all over the world, the impacts of gross domestic product (GDP) are also included in the model. Overall, the results imply that the percentage of daily trips by public transport, the percentage of daily trips on foot and by bicycle, and the GDP per inhabitant have negative relationships with t...Continue Reading

References

Jun 1, 1995·Accident; Analysis and Prevention·V ShankarW Barfield
Oct 1, 1995·Accident; Analysis and Prevention·N LevineL H Nitz
Nov 25, 1997·Accident; Analysis and Prevention·V ShankarF Mannering
Jun 28, 2000·International Journal of Epidemiology·E F van BeeckJ P Mackenbach
Jul 25, 2000·Accident; Analysis and Prevention·M A Abdel-Aty, A E Radwan
Oct 24, 2003·Accident; Analysis and Prevention·Robert B Noland, Mohammed A Quddus
Dec 4, 2003·Accident; Analysis and Prevention·Xiao QinNalini Ravishanker
Sep 8, 2004·Accident; Analysis and Prevention·David E Clark, Brad M Cushing
Dec 21, 2004·Accident; Analysis and Prevention·Elizabeth Kopits, Maureen Cropper
Sep 8, 2005·Health Economics·David BishaiAbdul Ghaffar
Oct 26, 2005·American Journal of Preventive Medicine·Lilah M Besser, Andrew L Dannenberg
Jan 18, 2006·Accident; Analysis and Prevention·Alireza HadayeghiCarl Cheung
Feb 18, 2006·Traffic Injury Prevention·Sergey Y Kyrychenko, Anne T McCartt
Jul 21, 2006·Traffic Injury Prevention·A K Ibrahim SheikhHariza Ahmed
Sep 29, 2006·Accident; Analysis and Prevention·Joon-Ki KimLuis A Porrello
Dec 13, 2006·Accident; Analysis and Prevention·Sudeshna Mitra, Simon Washington
Apr 10, 2008·Traffic Injury Prevention·Gong-Li LiQi-En Cai
Aug 5, 2009·Injury Prevention : Journal of the International Society for Child and Adolescent Injury Prevention·Tamitza Toroyan
Nov 6, 2009·Accident; Analysis and Prevention·Ali Naderan, Jalil Shahi
Feb 18, 2010·Accident; Analysis and Prevention·Alireza HadayeghiBhagwant N Persaud
Jul 14, 2010·American Journal of Preventive Medicine·John M MacDonaldGreg K Ridgeway
Aug 20, 1991·Applied Optics·K Sassen
Jan 25, 2011·Traffic Injury Prevention·James V Ouellet
Mar 8, 2011·Accident; Analysis and Prevention·Wesley Earl Marshall, Norman W Garrick
Jun 11, 2011·Accident; Analysis and Prevention·Dominique Lord, Srinivas Reddy Geedipally
Jun 11, 2011·Accident; Analysis and Prevention·Xinping YanChaozhong Wu
Nov 9, 2011·Accident; Analysis and Prevention·Fred WegmanAtze Dijkstra
Nov 9, 2011·Accident; Analysis and Prevention·Vicky Feng Wei, Gord Lovegrove
Jan 25, 2012·Accident; Analysis and Prevention·Srinivas Reddy GeedipallySoma Sekhar Dhavala
Mar 21, 2012·Traffic Injury Prevention·Aruna ChandranUNKNOWN Vida No Transito Evaluation Team
Jul 24, 2012·Traffic Injury Prevention·Henk Stipdonk, Martine Reurings
Jan 22, 2013·Accident; Analysis and Prevention·Hong Son NghiemSusan Gargett
Jan 23, 2013·Accident; Analysis and Prevention·Cara Hamann, Corinne Peek-Asa
Feb 28, 2013·Traffic Injury Prevention·Hamed Al-ReesiAbdullah Al-Maniri
Jul 23, 2013·Accident; Analysis and Prevention·Soyoung JungYoonjin Yoon
Oct 29, 2013·Accident; Analysis and Prevention·Younshik ChungByoung-Jo Yoon
Apr 1, 2013·Journal of Transport Geography·Andrew CarseDavid Ogilvie
Jul 2, 2014·Traffic Injury Prevention·Zohreh Asadi-ShekariMuhammad Zaly Shah
Mar 21, 2015·Traffic Injury Prevention·Millicent Awialie AkaatebaBernard Afiik Akanpabadai Akanbang
Jun 2, 2015·Traffic Injury Prevention·Yutaka AikyoMakoto Ishiwatari

❮ Previous
Next ❯

Citations

Oct 8, 2016·Traffic Injury Prevention·Mohammad FararoueiGholamhossein Shahraki
Dec 20, 2019·Accident; Analysis and Prevention·Mohammad Mehdi BesharatiCarlo G Prato

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.